Advertisement
Screener

ROCKEFELLER FINANCIAL SERVICES INC Historic Quarter Change: Foreign Stocks, Added

ROCKEFELLER FINANCIAL SERVICES INC historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, ROCKEFELLER FINANCIAL SERVICES INC opened 51 positions, added to 86, reduced 92 and sold out of 63.

  • Q3 2016: Stock BP; Country of operation —; Class ADR; Shares before 320,984.
  • Q3 2016: Stock ULXXXX; Country of operation —; Class ADR; Shares before 244,864.
  • Q3 2016: Stock ABBNY; Country of operation Switzerland; Class ADR; Shares before 12,062.
  • Q2 2016: Stock BP; Country of operation —; Class ADR; Shares before 310,790.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 869878), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-10-28); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-20); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-28); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-03); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-23); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-05); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-28); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-05); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-25); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-05); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-03); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-25). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 1999-03-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016BP
BP PLC - Spons ADR
ADR320,9841,894,354+1,573,370$11,398,000$66,605,000+$55,207,0002016-10-28
Q3 2016ULXXXX
Unilever Plc - Sponsored ADR
ADR244,864256,127+11,263$11,731,000$12,140,000+$409,0002016-10-28
Q3 2016ABBNY
ABB Ltd. - Spon ADR
SwitzerlandADR12,06212,641+579$239,000$285,000+$46,0002016-10-28
Q2 2016BP
BP PLC - Spons ADR
ADR310,790320,984+10,194$9,380,000$11,398,000+$2,018,0002016-07-20
Q2 2016ULXXXX
Unilever Plc - Sponsored ADR
ADR243,702244,864+1,162$11,011,000$11,731,000+$720,0002016-07-20
Q2 2016KEP
Korea Electric Power Corp. SP ADR
ADR1,202,2591,211,629+9,370$30,958,000$31,417,000+$459,0002016-07-20
Q2 2016KT
KT Corporation Sponsored ADR
ADR99,226108,141+8,915$1,332,000$1,542,000+$210,0002016-07-20
Q2 2016HDB
HDFC Bank Ltd. - ADR
ADR9,2779,609+332$572,000$638,000+$66,0002016-07-20
Q2 2016ITUB
Itau Unibanco Holdings SA - Pref ADR
ADR55,16357,132+1,969$474,000$539,000+$65,0002016-07-20
Q2 2016CUK
Carnival PLC - ADR
ADR3,6093,836+227$196,000$172,000-$24,0002016-07-20
Q2 2016IBN
Icici Bank Limited - Spon ADR
ADR70,62872,580+1,952$506,000$521,000+$15,0002016-07-20
Q1 2016ULXXXX
Unilever Plc - Sponsored ADR
ADR232,740243,702+10,962$10,037,000$11,011,000+$974,0002016-04-28
Q1 2016NTTYY
Nippon Telegraph & Telephone Corporation
JapanADR69,12070,554+1,434$2,747,000$3,051,000+$304,0002016-04-28
Q1 2016BP
BP PLC - Spons ADR
ADR308,555310,790+2,235$9,645,000$9,380,000-$265,0002016-04-28
Q1 2016ABBNY
ABB Ltd. - Spon ADR
SwitzerlandADR12912,191+12,062$2,000$237,000+$235,0002016-04-28
Q1 2016FMX
Fomento Economico Mexicano, S.A.-Sp ADR
ADR7,6447,698+54$706,000$741,000+$35,0002016-04-28
Q1 2016TEVA
Teva Pharmaceutical Industries Ltd. ADR
ADR1,8472,910+1,063$121,000$156,000+$35,0002016-04-28
Q1 2016TSM
Taiwan Semiconductor Manufacturing
ADR5,6986,122+424$130,000$160,000+$30,0002016-04-28
Q1 2016IBN
Icici Bank Limited - Spon ADR
ADR67,25470,628+3,374$527,000$506,000-$21,0002016-04-28
Q1 2016NVO
Novo Nordisk A/S-Spons ADR
ADR27,33529,005+1,670$1,588,000$1,572,000-$16,0002016-04-28
Q1 2016WPP
WPP Group PLC - Sponsored ADR
ADR216328+112$25,000$38,000+$13,0002016-04-28
Q1 2016HMC
Honda Motor Co., Ltd
ADR106451+345$3,000$12,000+$9,0002016-04-28
Q1 2016CUK
Carnival PLC - ADR
ADR3,3353,609+274$190,000$196,000+$6,0002016-04-28
Q4 2015BP
BP PLC - Spons ADR
ADR306,372308,555+2,183$9,363,000$9,645,000+$282,0002016-02-03
Q3 2015SNY
Sanofi-Aventis - ADR
ADR201,373396,776+195,403$9,974,000$18,835,000+$8,861,0002015-10-23
Q3 2015NVS
Novartis AG - ADR
ADR1,144,6601,166,109+21,449$112,565,000$107,189,000-$5,376,0002015-10-23
Q3 2015BP
BP PLC - Spons ADR
ADR299,001306,372+7,371$11,948,000$9,363,000-$2,585,0002015-10-23
Q3 2015NTTYY
Nippon Telegraph & Telephone Corporation
JapanADR63,08876,282+13,194$2,289,000$2,694,000+$405,0002015-10-23
Q3 2015KEP
Korea Electric Power Corp. SP ADR
ADR1,260,6801,261,165+485$25,668,000$25,841,000+$173,0002015-10-23
Q3 2015IBN
Icici Bank Limited - Spon ADR
ADR65,99467,254+1,260$688,000$564,000-$124,0002015-10-23
Q3 2015SNN
Smith & Nephew plc ADR
ADR12,50212,818+316$424,000$449,000+$25,0002015-10-23
Q3 2015TEVA
Teva Pharmaceutical Industries Ltd. ADR
ADR1,3501,847+497$80,000$104,000+$24,0002015-10-23
Q3 2015NVO
Novo Nordisk A/S-Spons ADR
ADR27,33527,522+187$1,497,000$1,493,000-$4,0002015-10-23
Q2 2015ULXXXX
Unilever Plc - Sponsored ADR
ADR164,608249,878+85,270$6,866,000$10,734,000+$3,868,0002015-07-14
Q2 2015NVS
Novartis AG - ADR
ADR1,121,1941,144,660+23,466$110,561,000$112,565,000+$2,004,0002015-07-14
Q2 2015SNY
Sanofi-Aventis - ADR
ADR190,411201,373+10,962$9,413,000$9,974,000+$561,0002015-07-14
Q2 2015BBVA
Banco Bilbao Vizcaya Argentaria S.A. Adr
ADR41,35189,806+48,455$415,000$886,000+$471,0002015-07-14
Q2 2015NTTYY
Nippon Telegraph & Telephone Corporation
JapanADR62,83463,088+254$1,937,000$2,289,000+$352,0002015-07-14
Q2 2015IBN
Icici Bank Limited - Spon ADR
ADR53,39865,994+12,596$553,000$688,000+$135,0002015-07-14
Q2 2015KEP
Korea Electric Power Corp. SP ADR
ADR1,246,8191,260,680+13,861$25,560,000$25,668,000+$108,0002015-07-14
Q2 2015SNN
Smith & Nephew plc ADR
ADR11,41212,502+1,090$390,000$424,000+$34,0002015-07-14
Q1 2015SNY
Sanofi-Aventis - ADR
ADR91,846190,411+98,565$4,188,000$9,413,000+$5,225,0002015-05-05
Q1 2015ULXXXX
Unilever Plc - Sponsored ADR
ADR96,116164,608+68,492$3,891,000$6,866,000+$2,975,0002015-05-05
Q1 2015TEVA
Teva Pharmaceutical Industries Ltd. ADR
ADR2,1404,850+2,710$123,000$302,000+$179,0002015-05-05
Q1 2015SGMOQ
Sangamo Biosciences, Inc.
United StatesCommon5,6978,444+2,747$87,000$132,000+$45,0002015-05-05
Q1 2015SNN
Smith & Nephew plc ADR
ADR9,69411,412+1,718$356,000$390,000+$34,0002015-05-05
Q1 2015IBN
Icici Bank Limited - Spon ADR
ADR50,30053,398+3,098$581,000$553,000-$28,0002015-05-05
Q1 2015TSM
Taiwan Semiconductor Manufacturing
ADR4,8105,698+888$108,000$134,000+$26,0002015-05-05
Q1 2015VALE
Vale SA (ADR)
ADR44102+58$0$1,000+$1,0002015-05-05
Q4 2014KEP
Korea Electric Power Corp. SP ADR
ADR1,238,3851,253,697+15,312$27,789,000$24,272,000-$3,517,0002015-01-28
Q4 2014TEVA
Teva Pharmaceutical Industries Ltd. ADR
ADR1,3502,140+790$73,000$123,000+$50,0002015-01-28
Q4 2014SNN
Smith & Nephew plc ADR
ADR4,0689,694+5,626$342,000$356,000+$14,0002015-01-28
Q3 2014KEP
Korea Electric Power Corp. SP ADR
ADR931,3731,238,385+307,012$17,137,000$27,789,000+$10,652,0002014-11-05
Q3 2014NVS
Novartis AG - ADR
ADR1,096,8451,154,527+57,682$99,297,000$108,675,000+$9,378,0002014-11-05
Q3 2014ULXXXX
Unilever Plc - Sponsored ADR
ADR81,88496,316+14,432$3,710,000$4,035,000+$325,0002014-11-05
Q2 2014NVS
Novartis AG - ADR
ADR1,075,6931,096,845+21,152$91,455,000$99,297,000+$7,842,0002014-07-25
Q2 2014BP
BP PLC - Spons ADR
ADR540,081546,092+6,011$25,977,000$28,806,000+$2,829,0002014-07-25
Q2 2014KEP
Korea Electric Power Corp. SP ADR
ADR919,808931,373+11,565$15,793,000$17,137,000+$1,344,0002014-07-25
Q2 2014ULXXXX
Unilever Plc - Sponsored ADR
ADR80,91881,884+966$3,462,000$3,710,000+$248,0002014-07-25
Q2 2014VOD
Vodafone Group PLC - SP ADR
ADR44,16950,267+6,098$1,626,000$1,679,000+$53,0002014-07-25
Q2 2014TEVA
Teva Pharmaceutical Industries Ltd. ADR
ADR1,3501,820+470$71,000$95,000+$24,0002014-07-25
Q2 2014ABBNY
ABB Ltd. - Spon ADR
SwitzerlandADR1291,127+998$3,000$26,000+$23,0002014-07-25
Q2 2014MUFG
Mitsubishi UFJ Financial Group, Inc.
ADR5004,094+3,594$3,000$25,000+$22,0002014-07-25
Q1 2014NVS
Novartis AG - ADR
ADR1,039,3411,075,693+36,352$83,542,000$91,455,000+$7,913,0002014-05-05
Q1 2014NVO
Novo Nordisk A/S-Spons ADR
ADR96,152480,635+384,483$17,765,000$21,941,000+$4,176,0002014-05-05
Q1 2014KEP
Korea Electric Power Corp. SP ADR
ADR867,455919,808+52,353$14,408,000$15,793,000+$1,385,0002014-05-05
Q1 2014BP
BP PLC - Spons ADR
ADR521,592540,081+18,489$25,355,000$25,977,000+$622,0002014-05-05
Q1 2014RIO
Rio Tinto plc - Spon ADR
ADR895,801915,597+19,796$50,551,000$51,118,000+$567,0002014-05-05
Q1 2014DEO
Diageo Plc - sponsored ADR
ADR301,070+1,040$4,000$133,000+$129,0002014-05-05
Q1 2014SGMOQ
Sangamo Biosciences, Inc.
United StatesCommon13,66614,168+502$190,000$256,000+$66,0002014-05-05
Q1 2014SBS
Companhia de Saneamento Basico do Estado
ADR24,36031,264+6,904$276,000$290,000+$14,0002014-05-05
Q4 2013NVS
Novartis AG - ADR
ADR981,6611,039,341+57,680$75,303,000$83,542,000+$8,239,0002014-02-03
Q4 2013BP
BP PLC - Spons ADR
ADR447,755521,592+73,837$18,819,000$25,355,000+$6,536,0002014-02-03
Q4 2013KEP
Korea Electric Power Corp. SP ADR
ADR718,346867,455+149,109$10,086,000$14,408,000+$4,322,0002014-02-03
Q4 2013UGP
Ultrapar Participacoes SA - Spons ADR
ADR5,85086,627+80,777$144,000$2,048,000+$1,904,0002014-02-03
Q4 2013NVO
Novo Nordisk A/S-Spons ADR
ADR95,65296,152+500$16,186,000$17,765,000+$1,579,0002014-02-03
Q4 2013SNY
Sanofi-Aventis - ADR
ADR128,027135,083+7,056$6,483,000$7,245,000+$762,0002014-02-03
Q4 2013VALE
Vale SA (ADR)
ADR3,34419,044+15,700$52,000$290,000+$238,0002014-02-03
Q4 2013RDY
Dr. Reddy's Laboratories Limited - ADR
ADR3,3844,458+1,074$128,000$183,000+$55,0002014-02-03
Q4 2013SGMOQ
Sangamo Biosciences, Inc.
United StatesCommon13,54413,666+122$142,000$190,000+$48,0002014-02-03
Q3 2013NVS
Novartis AG - ADR
ADR958,535981,661+23,126$67,779,000$75,303,000+$7,524,0002013-10-25
Q3 2013KEP
Korea Electric Power Corp. SP ADR
ADR671,400718,346+46,946$7,594,000$10,086,000+$2,492,0002013-10-25
Q3 2013BP
BP PLC - Spons ADR
ADR422,279447,755+25,476$17,626,000$18,819,000+$1,193,0002013-10-25
Q3 2013SNY
Sanofi-Aventis - ADR
ADR104,190128,027+23,837$5,367,000$6,483,000+$1,116,0002013-10-25
Q3 2013ING
ING Groep N.V. - Sponsored ADR
ADR67,260101,400+34,140$611,000$1,151,000+$540,0002013-10-25
Q3 2013VALE
Vale SA (ADR)
ADR3,3003,344+44$43,000$52,000+$9,0002013-10-25

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet